Our client Exact Sciences has had enormous success with their non-invasive colon cancer test. It is a test that widely adopted, has the real possibility of virtually eradicating colon cancer. Last Friday night CEO Kevin Conroy appeared on Jim Cramers CNBC show. Take a look.Posted in Editorials
The Great Lakes Restoration Initiative is zeroed out in the proposed FY 18 budget.
Regardless of party or ideology this is a bad idea. Please see the attached editorial in the Milwaukee Journal Sentinel.
I hope you will support the restoration of all of the funds in the FY18 budget. The Great Lakes are a valuable resource and the clean up leads to economic development and creation of more employment in the regions. Letting your elected representative know you views on this issue will make a big difference.
If you need any more info please feel to contact me.Posted in Editorials
Yesterday the Wisconsin Cranberry Association’s Foundation announced the purchase of a site for a research station for cranberries.
This public-private partnership which establishes a permanent site for cranberry research in Wisconsin is thanks to efforts of our Congressional delegation especially Senator Tammy Baldwin and contributions from cranberry farmers themselves.
Wisconsin is the world’s leading producer of cranberries. Research will improve productivity, quality, and the conservation of water resources. We commend everyone involved.Posted in Editorials
Today, our friend and neighbor, Bob Lighthizer will be sworn in as the U.S. Special Trade Representative. He will be the President’s Principal Advisor on Trade Policy.
He was confirmed by wide bipartisan vote of 82-14 last Thursday.
While I may not agree with Bob all of the time, he is an outstanding choice. He is extremely bright, well-versed, and has a deep understanding of the enormously complex world of trade.
He served as the Deputy Trade Representative in the Reagan administration and previously had run the Senate Finance Committee for Senator Bob Dole.
He will do an outstanding job and is seeking to make some fundamental changes in our trade policy.
We wish him the best of luck!Posted in Editorials
Visits to the Hill with Joseph Sumner, Vicki Trebian and Tiffany Walker, of ATTIC: Wisconsin’s largest correction service company.
While we were there, we saw Matt Lauer walking through the Capitol in preparation for the next day’s Today show!
Posted in Editorials
My friend and client Dr. Joe Tector is doing extraordinary work on solving the problem of the shortage of organs for transplantation. Through his research as shown in this Wall Street Journal article it may be possible to develop pig organs that can be transplanted into humans. Today, thousands die because of organ shortages and if his research is successful there will be stunning paradigm shift in organ transplantation eliminating the shortage of organs.
I have been proud to represent Dr. Tector and his father Dr. Cy Tector who pioneered the transplant program at St. Luke’s Aurora in Milwaukee.
I am confident Joe’s work will be successful and a major health problem solved.Posted in Editorials
As of the most recent update to TRICARE’s preventive services policies, Exact Science’s Cologuard – the most effective, non-invasive colorectal cancer screening exam – is now given first-dollar coverage for 9.4 million active-duty, reserve, and National Guard personnel, veterans, and their dependents. The revision brings TRICARE into compliance with the most recent United States Preventive Services Task Force (USPSTF) colorectal cancer screening recommendations that include Cologuard as an A-rated option for preventive care.
In August 2014, Cologuard made history when it became the first ever product to receive FDA approval and a nationwide Medicare coverage decision on the same day. Since then, Cologuard has been A-rated by the USPSTF, included in the National Committee for Quality Assurance’s (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS), and affirmed by Medicare Advantage.
Given the devastating mortality rate of late stage colorectal cancer, providing first-dollar coverage for the non-invasive, high-sensitivity Cologuard option is a crucial milestone. With clear direction from the USPSTF’s recommendations, TRICARE’s move into compliance should prove a strong signal to insurers nation-wide that first-dollar coverage for Cologuard is the clear checkmate move in the fight against the second leading cause of cancer deaths in America.Posted in Editorials
As of three days ago Exact Sciences’ Cologuard – the most effective, non-invasive colorectal cancer screening exam – is now included in the National Committee for Quality Assurance’s (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS). Inclusion in HEDIS means that physicians will receive quality credit for providing patients an exam given an “A” rating by the United States Preventative Services Taskforce (USPSTF). Earning quality credits is part of the overall movement towards Value Based Purchasing (VBP) that entitles providers to bonuses based on quality improvement. We applaud NCQA for its decision, marking a reaffirmation of our nation’s commitment to fight colorectal cancer – the second leading cause of cancer deaths in America.
The decision marks yet another milestone for Cologuard on its path to nationwide, first-dollar coverage that already includes becoming the first product ever to simultaneously receive FDA approval and a Medicare coverage decision, A-rated by the USPSTF, and affirmed by Medicare Advantage.